Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020639 (
hypoproteinemia
)
1,134
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein-losing enteropathy (PLE) is a clinical disorder of protein loss from the gastrointestinal system that results in
hypoproteinemia
and malnutrition. This condition is associated with a wide range of gastrointestinal disorders. Recently, a unique syndrome of congenital PLE associated with biallelic mutations in the
DGAT1
gene has been reported in a single family. We hypothesize that mutations in this gene are responsible for undiagnosed cases of PLE in infancy. Here we investigated three children in two families presenting with severe diarrhea, hypoalbuminemia and PLE, using clinical studies, homozygosity mapping, and exome sequencing. In one family, homozygosity mapping using SNP arrays revealed the
DGAT1
gene as the best candidate gene for the proband. Sequencing of all the exons including flanking regions and promoter regions of the gene identified a novel homozygous missense variant, p.(Leu295Pro), in the highly conserved membrane-bound O-acyl transferase (MBOAT) domain of the DGAT1 protein. Expression studies verified reduced amounts of
DGAT1
in patient fibroblasts. In a second family, exome sequencing identified a previously reported splice site mutation in intron 8. These cases of
DGAT1
deficiency extend the molecular and phenotypic spectrum of PLE, suggesting a re-evaluation of the use of
DGAT1
inhibitors for metabolic disorders including obesity and diabetes.
...
PMID:Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations. 2688 93